Approval · Notice of Compliance 24969 · 2021
RETIN-A: Notice of Compliance 24969
Issued January 8, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24969
- Date
- January 8, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RETIN-A | 02510243 | Approved |
Medicinal ingredients
- TRETINOIN 0.05 PER